CNE100002219
CNE100002219
HEILONGJIANG ZBD PHARMACEUTICAL
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 798.063.745 | 2.706.503.666 | 70.5% |
| Cost of Revenue | 820.121.909 | 1.215.053.991 | 32.5% |
| Gross Profit | -22.058.164 | 1.491.449.675 | 101.5% |
| 395.800.331 | 633.187.799 | 37.5% | |
| Operating Income | -417.858.495 | 858.261.876 | 148.7% |
| Pretax Income | -1.627.401.874 | 523.471.915 | 410.9% |
| Net Income Common Stockholders | -1.366.528.672 | 438.216.196 | 411.8% |
| -- | -- | -- | |
| -- | -- | -- |